Tag: genomics
-
BioNTech to Provide Personal Cancer Immunotherapies in UK
The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030.
-
Biotech Alliance Creating Circular RNA Cancer Drug
A partnership of biotechnology components and therapy companies aims to develop new drugs made from circular forms of RNA, starting with a colorectal cancer treatment.
-
Company Started for Gene Editing Rare Inherited Diseases
A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells.
-
Trial Testing Ultrasound for Brain Cancer Liquid Biopsies
A clinical trial is underway testing the safety and feasibility of focused ultrasound to enable use of blood tests to monitor a patient’s glioblastoma, a form of brain cancer.
-
New Company Creating High-Capacity Gene Therapies to the Brain
A new business is underway developing gene therapies with higher capacities than most current technologies to treat neurodegenerative disorders.
-
Trial Underway for Kidney Disease Microbiome Therapy
A clinical trial enrolled its first participant testing an engineered bacterial collection as a treatment for enteric hyperoxaluria, a kidney disorder with no approved cure.
-
DNA Storage Start-Up Gains €5M in Seed Funds
A new company developing DNA as a data storage medium with sustainable processes is raising €5 million ($US 5.22 million) in seed funding.
-
Residual Cancer Detection Company Launches, Raises $56M
A start-up enterprise developing personalized liquid biopsies for finding residual cancer in patients is beginning work and raising $56 million in venture funds.
-
Biotech, M.D. Anderson Partner on Precision Drug Design
A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines.
-
Neurons Identified, Stimulated for Spinal Cord Repair
Spinal cord injury patients in a clinical trial received electronic stimulation to a specified set of nerve cells that enabled them to restore walking after rehabilitation.